Human muscle-derived stem cells effective in animal models of incontinence
Researchers have successfully used human muscle-derived stem cells to restore leak-point pressure in animal models of stress urinary incontinence. The therapy involves injecting the cells into the periurethral muscle, which differentiates into new muscle fibers to prevent atrophy. Clinical trials are underway in Toronto.